Package 42291-041-90

Brand: lisdexamfetamine dimesylate

Generic: lisdexamfetamine
NDC Package

Package Facts

Identity

Package NDC 42291-041-90
Digits Only 4229104190
Product NDC 42291-041
Product ID 42291-041_36c401bd-e228-6fbd-e063-6394a90a5f1f
Description

90 CAPSULE in 1 BOTTLE (42291-041-90)

Marketing

Marketing Status
Marketed Since 2025-06-04
Brand lisdexamfetamine dimesylate
Generic lisdexamfetamine
Sample Package No

Linked Drug Pages (1)

Lisdexamfetamine Dimesylate ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "36c401bd-e228-6fbd-e063-6394a90a5f1f", "openfda": {"unii": ["SJT761GEGS"], "rxcui": ["854830", "854834", "854838", "854842", "854846", "854850"], "spl_set_id": ["36c40404-fe94-6fb7-e063-6394a90a2657"], "manufacturer_name": ["AvKARE"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "90 CAPSULE in 1 BOTTLE (42291-041-90)", "package_ndc": "42291-041-90", "marketing_start_date": "20250604"}], "brand_name": "Lisdexamfetamine Dimesylate", "product_id": "42291-041_36c401bd-e228-6fbd-e063-6394a90a5f1f", "dosage_form": "CAPSULE", "pharm_class": ["Central Nervous System Stimulant [EPC]", "Central Nervous System Stimulation [PE]"], "product_ndc": "42291-041", "dea_schedule": "CII", "generic_name": "Lisdexamfetamine", "labeler_name": "AvKARE", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Lisdexamfetamine Dimesylate", "active_ingredients": [{"name": "LISDEXAMFETAMINE DIMESYLATE", "strength": "70 mg/1"}], "application_number": "ANDA202830", "marketing_category": "ANDA", "marketing_start_date": "20250604", "listing_expiration_date": "20261231"}